GlassScriptPhysician profile
Erin D Smith
NPI 1023733300
$2,048.83
in general payments reported to CMS, 2019-2025
13 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.91 · 2023: $1,078 · 2024: $468 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.19 |
| Travel and Lodging | $752.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $875.26 | 2023 | |
| Sandoz INC. | $780.04 | 2023-2025 | Hyrimoz, Jubbonti |
| Medtronic, INC. | $64.02 | 2024 | Venaseal |
| Painteq LLC | $56.00 | 2023 | Painteq |
| Biotronik Nro, INC. | $50.76 | 2025 | Prospera |
| Ani Pharmaceuticals, INC. | $48.78 | 2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.77 | 2023 | Jardiance |
| Janssen Biotech, INC. | $26.41 | 2024 | Simponi Aria |
| Lilly USA, LLC | $25.97 | 2025 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.82 | 2025 | Caplyta |
| Boston Scientific Corporation | $23.91 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.90 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.